146 related articles for article (PubMed ID: 10867151)
1. TP53 deletions but not trisomy 12 are adverse in B-cell lymphoproliferative disorders.
Shaw GR; Kronberger DL
Cancer Genet Cytogenet; 2000 Jun; 119(2):146-54. PubMed ID: 10867151
[TBL] [Abstract][Full Text] [Related]
2. Genetic abnormalities in chronic lymphocytic leukemia and their clinical and prognostic implications.
Dierlamm J; Michaux L; Criel A; Wlodarska I; Van den Berghe H; Hossfeld DK
Cancer Genet Cytogenet; 1997 Mar; 94(1):27-35. PubMed ID: 9078288
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and P53 monoallelic gene deletions in B-cell chronic lymphocytic leukemia by fluorescence in situ hybridization (FISH): relation to disease status.
Lazaridou A; Miraxtsi C; Korantzis J; Eleftheriadis N; Christakis JI
Leuk Lymphoma; 2000 Feb; 36(5-6):503-12. PubMed ID: 10784395
[TBL] [Abstract][Full Text] [Related]
4. Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.
Döhner H; Stilgenbauer S; Döhner K; Bentz M; Lichter P
J Mol Med (Berl); 1999 Feb; 77(2):266-81. PubMed ID: 10023780
[TBL] [Abstract][Full Text] [Related]
5. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part I. B-cell lymphocytic leukemia with TP53 gene deletion].
Koczkodaj D; Rupniewska ZM; Wasik-Szczepanek E; Bojarska-Junak A
Pol Arch Med Wewn; 2003 Dec; 110(6):1395-403. PubMed ID: 15052934
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of ATM and TP53 deletions in Chinese patients with chronic lymphocytic leukemia.
Xu W; Li JY; Wu YJ; Yu H; Shen QD; Li L; Fan L; Qiu HX
Leuk Res; 2008 Jul; 32(7):1071-7. PubMed ID: 18035414
[TBL] [Abstract][Full Text] [Related]
7. [Some genomic aberrations in B-cell chronic lymphocytic leukemia and their clinical relevance. Part II. Trisomy 12 in B-cell chronic lymphocytic leukemia detected by fluorescence in situ hybridization].
Wasik-Szczepanek E; Rupniewska ZM; Koczkodaj D; Bojarska A
Pol Arch Med Wewn; 2003 Dec; 110(6):1431-8. PubMed ID: 15052938
[TBL] [Abstract][Full Text] [Related]
8. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
[TBL] [Abstract][Full Text] [Related]
9. The impact of trisomy 12, retinoblastoma gene and P53 in prognosis of B-cell chronic lymphocytic leukemia.
AbdelSalam M; El Sissy A; Samra MA; Ibrahim S; El Markaby D; Gadallah F
Hematology; 2008 Jun; 13(3):147-53. PubMed ID: 18702872
[TBL] [Abstract][Full Text] [Related]
10. Interphase fluorescence in situ hybridization analysis of del(11)(q23) and del(17)(p13) in chronic lymphocytic leukemia. a study of 40 early-onset patients.
Doneda L; Montillo M; Intropido L; Tedeschi A; Morra E; Larizza L
Cancer Genet Cytogenet; 2003 Jan; 140(1):31-6. PubMed ID: 12550755
[TBL] [Abstract][Full Text] [Related]
11. Trisomy 12 and p53 deletion in chronic lymphocytic leukemia detected by fluorescence in situ hybridization: association with morphology and resistance to conventional chemotherapy.
Cano I; Martinez J; Quevedo E; Pinilla J; Martin-Recio A; Rodriguez A; Castañeda A; López R; Pérez-Piño T; Hernández-Navarro F
Cancer Genet Cytogenet; 1996 Sep; 90(2):118-24. PubMed ID: 8830719
[TBL] [Abstract][Full Text] [Related]
12. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
[TBL] [Abstract][Full Text] [Related]
13. Trisomy 12 in Richter's transformation of chronic lymphocytic leukemia.
Brynes RK; McCourty A; Sun NC; Koo CH
Am J Clin Pathol; 1995 Aug; 104(2):199-203. PubMed ID: 7639196
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic and molecular cytogenetic analysis of B cell chronic lymphocytic leukemia: specific chromosome aberrations identify prognostic subgroups of patients and point to loci of candidate genes.
Döhner H; Stilgenbauer S; Fischer K; Bentz M; Lichter P
Leukemia; 1997 Apr; 11 Suppl 2():S19-24. PubMed ID: 9178833
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia.
Liso V; Capalbo S; Lapietra A; Pavone V; Guarini A; Specchia G
Haematologica; 1999 Mar; 84(3):212-7. PubMed ID: 10189384
[TBL] [Abstract][Full Text] [Related]
16. Genomic aberrations and survival in chronic lymphocytic leukemia.
Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
[TBL] [Abstract][Full Text] [Related]
17. Genetics and risk-stratified approach to therapy in chronic lymphocytic leukemia.
Zenz T; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2007 Sep; 20(3):439-53. PubMed ID: 17707832
[TBL] [Abstract][Full Text] [Related]
18. Interphase cytogenetics in chronic lymphocytic leukemia.
Garcia-Marco JA; Price CM; Catovsky D
Cancer Genet Cytogenet; 1997 Mar; 94(1):52-8. PubMed ID: 9078291
[TBL] [Abstract][Full Text] [Related]
19. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
[TBL] [Abstract][Full Text] [Related]
20. "Double-hit" chronic lymphocytic leukemia: An aggressive subgroup with 17p deletion and 8q24 gain.
Chapiro E; Lesty C; Gabillaud C; Durot E; Bouzy S; Armand M; Le Garff-Tavernier M; Bougacha N; Struski S; Bidet A; Laharanne E; Barin C; Veronese L; Prié N; Eclache V; Gaillard B; Michaux L; Lefebvre C; Gaillard JB; Terré C; Penther D; Bastard C; Nadal N; Fert-Ferrer S; Auger N; Godon C; Sutton L; Tournilhac O; Susin SA; Nguyen-Khac F;
Am J Hematol; 2018 Mar; 93(3):375-382. PubMed ID: 29194741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
